世界のナチュラルキラー（NK）細胞治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Natural Killer (NK) Cell Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5876 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ナチュラルキラー（NK）細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モガムリズマブ、ロルボツズマブメルタンシン、その他）、用途別市場規模（がん、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ナチュラルキラー（NK）細胞治療の市場動向 ・企業の競争状況、市場シェア ・ナチュラルキラー（NK）細胞治療の種類別市場規模と予測2016-2027（モガムリズマブ、ロルボツズマブメルタンシン、その他） ・ナチュラルキラー（NK）細胞治療の用途別市場規模と予測2016-2027（がん、循環器疾患、その他） ・ナチュラルキラー（NK）細胞治療の北米市場規模2016-2027（アメリカ、カナダ） ・ナチュラルキラー（NK）細胞治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ナチュラルキラー（NK）細胞治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ナチュラルキラー（NK）細胞治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・ナチュラルキラー（NK）細胞治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Chipscreen Biosciences、Affimed NV、Altor BioScience、Innate Pharma、Takeda、Sorrento Therapeutics、NantKwest、Bristol-Myers Squibb、NKT、Henry Ford Health Services） ・結論

Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.

Market Analysis and Insights: Global Natural Killer (NK) Cell Therapeutics Market
The global Natural Killer (NK) Cell Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Natural Killer (NK) Cell Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Natural Killer (NK) Cell Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Natural Killer (NK) Cell Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Natural Killer (NK) Cell Therapeutics market.

Global Natural Killer (NK) Cell Therapeutics Scope and Market Size
Natural Killer (NK) Cell Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Natural Killer (NK) Cell Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mogamulizumab
Lorvotuzumab Mertansine
Others

Segment by Application
Cancer
Cardiovascular Diseases
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mogamulizumab
1.2.3 Lorvotuzumab Mertansine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Natural Killer (NK) Cell Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Natural Killer (NK) Cell Therapeutics Market Perspective (2016-2027)
2.2 Natural Killer (NK) Cell Therapeutics Growth Trends by Regions
2.2.1 Natural Killer (NK) Cell Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Natural Killer (NK) Cell Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Natural Killer (NK) Cell Therapeutics Industry Dynamic
2.3.1 Natural Killer (NK) Cell Therapeutics Market Trends
2.3.2 Natural Killer (NK) Cell Therapeutics Market Drivers
2.3.3 Natural Killer (NK) Cell Therapeutics Market Challenges
2.3.4 Natural Killer (NK) Cell Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Natural Killer (NK) Cell Therapeutics Revenue
3.4 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer (NK) Cell Therapeutics Revenue in 2020
3.5 Natural Killer (NK) Cell Therapeutics Key Players Head office and Area Served
3.6 Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
3.7 Date of Enter into Natural Killer (NK) Cell Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Natural Killer (NK) Cell Therapeutics Breakdown Data by Type
4.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2022-2027)

5 Natural Killer (NK) Cell Therapeutics Breakdown Data by Application
5.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Natural Killer (NK) Cell Therapeutics Market Size (2016-2027)
6.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Type
6.2.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2027)
6.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Application
6.3.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2027)
6.4 North America Natural Killer (NK) Cell Therapeutics Market Size by Country
6.4.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Natural Killer (NK) Cell Therapeutics Market Size (2016-2027)
7.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type
7.2.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2027)
7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application
7.3.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2027)
7.4 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country
7.4.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type
8.2.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application
8.3.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region
8.4.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size (2016-2027)
9.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type
9.2.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application
9.3.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country
9.4.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type
10.2.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application
10.3.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country
10.4.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Chipscreen Biosciences
11.1.1 Chipscreen Biosciences Company Details
11.1.2 Chipscreen Biosciences Business Overview
11.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Introduction
11.1.4 Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.1.5 Chipscreen Biosciences Recent Development
11.2 Affimed NV
11.2.1 Affimed NV Company Details
11.2.2 Affimed NV Business Overview
11.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Introduction
11.2.4 Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.2.5 Affimed NV Recent Development
11.3 Altor BioScience
11.3.1 Altor BioScience Company Details
11.3.2 Altor BioScience Business Overview
11.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Introduction
11.3.4 Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.3.5 Altor BioScience Recent Development
11.4 Innate Pharma
11.4.1 Innate Pharma Company Details
11.4.2 Innate Pharma Business Overview
11.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Introduction
11.4.4 Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.4.5 Innate Pharma Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Natural Killer (NK) Cell Therapeutics Introduction
11.5.4 Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.5.5 Takeda Recent Development
11.6 Sorrento Therapeutics
11.6.1 Sorrento Therapeutics Company Details
11.6.2 Sorrento Therapeutics Business Overview
11.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Introduction
11.6.4 Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.6.5 Sorrento Therapeutics Recent Development
11.7 NantKwest
11.7.1 NantKwest Company Details
11.7.2 NantKwest Business Overview
11.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Introduction
11.7.4 NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.7.5 NantKwest Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 NKT
11.9.1 NKT Company Details
11.9.2 NKT Business Overview
11.9.3 NKT Natural Killer (NK) Cell Therapeutics Introduction
11.9.4 NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.9.5 NKT Recent Development
11.10 Henry Ford Health Services
11.10.1 Henry Ford Health Services Company Details
11.10.2 Henry Ford Health Services Business Overview
11.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Introduction
11.10.4 Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.10.5 Henry Ford Health Services Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mogamulizumab
Table 3. Key Players of Lorvotuzumab Mertansine
Table 4. Key Players of Others
Table 5. Global Natural Killer (NK) Cell Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Natural Killer (NK) Cell Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Natural Killer (NK) Cell Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Natural Killer (NK) Cell Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Natural Killer (NK) Cell Therapeutics Market Share by Regions (2022-2027)
Table 11. Natural Killer (NK) Cell Therapeutics Market Trends
Table 12. Natural Killer (NK) Cell Therapeutics Market Drivers
Table 13. Natural Killer (NK) Cell Therapeutics Market Challenges
Table 14. Natural Killer (NK) Cell Therapeutics Market Restraints
Table 15. Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Natural Killer (NK) Cell Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Natural Killer (NK) Cell Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2020)
Table 18. Ranking of Global Top Natural Killer (NK) Cell Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
Table 22. Date of Enter into Natural Killer (NK) Cell Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Natural Killer (NK) Cell Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Chipscreen Biosciences Company Details
Table 63. Chipscreen Biosciences Business Overview
Table 64. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product
Table 65. Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Chipscreen Biosciences Recent Development
Table 67. Affimed NV Company Details
Table 68. Affimed NV Business Overview
Table 69. Affimed NV Natural Killer (NK) Cell Therapeutics Product
Table 70. Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Affimed NV Recent Development
Table 72. Altor BioScience Company Details
Table 73. Altor BioScience Business Overview
Table 74. Altor BioScience Natural Killer (NK) Cell Therapeutics Product
Table 75. Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Altor BioScience Recent Development
Table 77. Innate Pharma Company Details
Table 78. Innate Pharma Business Overview
Table 79. Innate Pharma Natural Killer (NK) Cell Therapeutics Product
Table 80. Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Innate Pharma Recent Development
Table 82. Takeda Company Details
Table 83. Takeda Business Overview
Table 84. Takeda Natural Killer (NK) Cell Therapeutics Product
Table 85. Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Takeda Recent Development
Table 87. Sorrento Therapeutics Company Details
Table 88. Sorrento Therapeutics Business Overview
Table 89. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product
Table 90. Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Sorrento Therapeutics Recent Development
Table 92. NantKwest Company Details
Table 93. NantKwest Business Overview
Table 94. NantKwest Natural Killer (NK) Cell Therapeutics Product
Table 95. NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 96. NantKwest Recent Development
Table 97. Bristol-Myers Squibb Company Details
Table 98. Bristol-Myers Squibb Business Overview
Table 99. Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Bristol-Myers Squibb Recent Development
Table 101. NKT Company Details
Table 102. NKT Business Overview
Table 103. NKT Natural Killer (NK) Cell Therapeutics Product
Table 104. NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 105. NKT Recent Development
Table 106. Henry Ford Health Services Company Details
Table 107. Henry Ford Health Services Business Overview
Table 108. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product
Table 109. Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Henry Ford Health Services Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Natural Killer (NK) Cell Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Mogamulizumab Features
Figure 3. Lorvotuzumab Mertansine Features
Figure 4. Others Features
Figure 5. Global Natural Killer (NK) Cell Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Cancer Case Studies
Figure 7. Cardiovascular Diseases Case Studies
Figure 8. Others Case Studies
Figure 9. Natural Killer (NK) Cell Therapeutics Report Years Considered
Figure 10. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Natural Killer (NK) Cell Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Natural Killer (NK) Cell Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Natural Killer (NK) Cell Therapeutics Market Share by Players in 2020
Figure 15. Global Top Natural Killer (NK) Cell Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue in 2020
Figure 17. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Natural Killer (NK) Cell Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Natural Killer (NK) Cell Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Natural Killer (NK) Cell Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Natural Killer (NK) Cell Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Region (2016-2027)
Figure 39. China Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Natural Killer (NK) Cell Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Natural Killer (NK) Cell Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Chipscreen Biosciences Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 59. Affimed NV Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 60. Altor BioScience Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 61. Innate Pharma Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 62. Takeda Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 63. Sorrento Therapeutics Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 64. NantKwest Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 66. NKT Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 67. Henry Ford Health Services Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---